Alpha Teknova, Inc.
As of Oct 22, 2026, Alpha Teknova is in Stage 2, the uptrend phase, now in week 18 (since Jun 23, 2026). It closed at $6.15, 34.1% below its 52-week high and above its 200-day average, which is rising.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 26 in Drug Manufacturers - Specialty & Generic · #1 of 272 in Health Care
Is TKNO early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
TKNO among Drug Manufacturers - Specialty & Generic24th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …24 | TKNO | Stage 2 · wk 18 | 62 | −31.1% |
Alpha Teknova: quick answers
What stage is Alpha Teknova in?
As of Oct 22, 2026, Alpha Teknova (TKNO) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 23, 2026 and is in week 18. What the four stages mean
Is Alpha Teknova in an uptrend?
Yes. Alpha Teknova is in a Stage 2 uptrend. It trades 28.4% above its 200-day average, which is rising.
How far is Alpha Teknova from its 52-week high?
Alpha Teknova closed at $6.15 on Oct 22, 2026, 34.1% below its 52-week high of $9.33. Its 52-week low is $1.99.
How has Alpha Teknova performed over the past year?
As of Oct 22, 2026, Alpha Teknova is up 9.4% over the past year and up 57.7% so far in 2026.
Which sector and industry is Alpha Teknova in?
Alpha Teknova is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.